UVM researcher makes strides in treatment for rare form of lung cancer wcax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wcax.com Daily Mail and Mail on Sunday newspapers.
Milestone for UVM-developed cancer drug | Vermont Business Magazine vermontbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vermontbiz.com Daily Mail and Mail on Sunday newspapers.
A clinical study at the University of Vermont Cancer Center has hit a milestone as research moves into Phase 2. The trial is developing a drug that could help cancer patients.
RS Oncology Announces New Preclinical Data Show RSO-021 May Block and/or Reverse the Progression of Aggressive Mesotheliomas, Improving Druggability finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Data presented by Dr. Dean Fennell in an oral presentation at the IASLC 2023 World Conference on Lung Cancer in SingaporeRS Oncology’s novel therapy RSO-021, a first-in-class inhibitor of the antioxidant protein PRX3, was shown to reverse many of the features associated with aggressive mesothelioma tumor growthCAMBR.